MRD Monitoring in Acute Lymphoblastic Leukemia
0 Bekeken
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Laat meer zien
Facebook Reacties
Geen reacties gevonden